Clinical Trials on Advanced Hodgkin Disease in Japan
Total 7067 results
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
Jichi Medical UniversityTakara Bio Inc.UnknownRelapsed or Refractory B-Cell Non-Hodgkin LymphomaJapan
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Spectrum Pharmaceuticals, IncBayerCompleted
-
BayerCompletedNon-Hodgkin's Lymphoma (NHL)Japan
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's LymphomaJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanTerminatedNon-Hodgkin's LymphomaJapan
-
TakedaCompletedPeripheral T Cell Lymphoma | Pediatric Hodgkin LymphomaJapan
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
Kyowa Kirin Co., Ltd.Active, not recruitingRelapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaJapan
-
TakedaRecruitingHodgkin LymphomaJapan
-
HUYABIO International, LLC.CompletedNon-Hodgkin's LymphomaJapan
-
AstraZenecaCompleted
-
Daiichi Sankyo Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Terminated
-
TakedaActive, not recruitingHodgkin DiseaseUnited States, Italy, Brazil, Japan
-
Novartis PharmaceuticalsCompleted
-
Eli Lilly and CompanyParexelCompleted
-
AstraZenecaCompleted
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
Toshihiko DoiMerck Sharp & Dohme LLC; Oncolys BioPharma IncCompleted
-
BayerCompletedNon-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Advanced Solid TumorUnited States, Canada, China, Japan, Singapore, United Kingdom, Switzerland
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.CompletedAdvanced Malignant Solid TumorsJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Nektar TherapeuticsCompleted
-
Bristol-Myers SquibbCompleted
-
Genta IncorporatedUnknown
-
Ono Pharmaceutical Co. LtdCompletedAdvanced or Metastatic Solid TumorsJapan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorJapan
-
Daiichi Sankyo Co., Ltd.Recruiting
-
Eli Lilly and CompanyCompleted
-
AstraZenecaCompletedAdvanced Solid TumoursJapan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsJapan
-
AstraZenecaCompleted
-
NovartisCompleted
-
3D Medicines (Sichuan) Co., Ltd.CompletedAdvanced or Metastatic Solid TumorsJapan
-
Eli Lilly and CompanyCompleted
-
Novartis PharmaceuticalsCompleted
-
Kohei ShitaraOno Pharmaceutical Co. Ltd; Bayer Yakuhin, Ltd.CompletedAdvanced and Metastatic Solid TumorJapan
-
Puma Biotechnology, Inc.CompletedAdvanced Malignant Solid TumorsJapan
-
AstraZenecaMedImmune LLCCompletedCancer | Advanced Solid MalignanciesJapan
-
Daiichi Sankyo Co., Ltd.CompletedAdvanced Solid Malignant TumorsJapan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
AstraZenecaActive, not recruiting
-
TakedaCompletedAdvanced Solid TumorsJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan